ShareValue scores for HKPD: Valuation 47, Quality 77, Growth 38, Health 50.

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares logo

HKPD
NASDAQ

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

$0.41(-0.12%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

6% to 15%
Valuation
47
Fair Value
Price vs Value
Quality
77
Strong
Business Strength
Growth
38
Weak
Revenue & Earnings
Health
50
Moderate
Financial Stability
Momentum
15
Bearish
Price Trend

Company Details

About

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026